Exscientia - Crunchbase Company Profile & Funding
Welsh scientist makes potential $539m fortune from biotech flotation in US | Pharmaceuticals industry | The Guardian
Exscientia and the University of Oxford announce partnership to develop treatments for Alzheimer's disease — Nuffield Department of Medicine
Exscientia and University of Oxford launch “Xcellomics” program to expedite early-stage academic research and translate novel biology into future drug discovery — University of Oxford, Medical Sciences Division
Exscientia and the University of Oxford announce partnership to develop treatments for Alzheimer's disease - Hub Publishing
Marco Derudas on LinkedIn: Exscientia Builds Automated Laboratories in Oxford to Expand Pipeline
Exscientia - Evotec
Riassunto: Exscientia presenta i dati sulla pipeline e sulla piattaforma per la medicina di precisione all'AACR | Business Wire
Double Dare: Exscientia Expands AI Platform into Antibody Design
Exscientia and the University of Oxford announce partnership to develop treatments for Alzheimer's disease | Business Wire
Andrew Hopkins of Exscientia: the man using AI to cure disease | Pharmaceuticals industry | The Guardian
Exscientia extends capabilities beyond small molecules - Drug Discovery World (DDW)
Exscientia appoints Oxford bioinformatics expert as first chief of biologics AI | Fierce Biotech
Exscientia raises $100m to build automated drug-hunting platform | Sifted
Working at Exscientia | Glassdoor
AI Drug Discovery Firm Exscientia Raises €23M and Signs with Roche
Leading AI-driven drug discovery company Exscientia expands to The Oxford Science Park | Commercial News Media
Exscientia, University of Oxford launch Xcellomics for drug discovery
Leading AI-driven drug discovery company Exscientia expands to The Oxford Science Park - TOSP
Significant expansion of AI firm Exscientia's headquarters at The Oxford Science Park | UKSPA
Exscientia | AI Drug Discovery | Pharmatech
Exscientia expands headquarters at The Oxford Science Park - The Business Magazine
